All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your PsOPsA Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Why do we have low adherence to psoriasis treatments and how do we improve that?
Featured
Bookmark this article
The Psoriasis and Psoriatic Arthritis Hub was pleased to speak to Steven R. Feldman, Wake Forest University, Winston-Salem, US. We asked, Why do we have low adherence to psoriasis treatments and how do we improve that?
Why do we have low adherence to psoriasis treatments and how do we improve that?
Feldman begins by pointing out that adherence to treatment is not the default and should not be assumed. It is then discussed how treatments can differ between localized and generalized psoriasis, and how doctors can increase treatment adherence in their patients.
More about...
Related articles
Newsletter
Subscribe to get the best content related to Psoriasis and Psoriatic Arthritis delivered to your inbox